Micrus Endovascular receives CE Mark clearance for Courier, Watusi

By Elaine Rigoli

Tampa, Fla., March 13 - Micrus Endovascular Corp. announced that it has received the CE Mark to market its Courier microcatheter line and Watusi guidewire platform in the European Union as well as all countries recognizing the CE Mark.

Micrus said it intends to begin selling these products through its direct sales and distribution network immediately.

"These product approvals, together with our Pharos stent approval in Europe announced earlier this month, significantly expand our ability to address the neurovascular procedure market," said John Kilcoyne, president and chief executive officer, in a statement.

Micrus said it is working to gain U.S. market approval for the Watusi and Courier.

By expanding its product offerings, the company said it hopes to compete for a greater percentage of the neurointerventional procedure market.

Micrus Endovascular develops, manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. The company is based in San Jose, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.